Family-owned drug factories in India erode US generic pricesPost published:August 31, 2017Post category:Industry NewsExpansion by Indian pharma firms is boosting competition in the US, where mergers and pricing wars among drugmakers had already been driving down cost of generics Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostRBI mandates 50% provisioning for NCLT cases Next PostHow Nandan Nilekani returned to Infosys You Might Also Like New RBI rules on provisioning, bad loans seen taking a toll on banks April 20, 2017 Metrology-Grade Desktop Scanner May Help Reduce Time to Market May 9, 2019 Rittal to introduce digital enclosure solutions at “The smarter E Europe” fair May 3, 2019